—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Hims Hers Health Inc (HIMS) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for HIMS, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 57/100 · S&P 500 fund at 71, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-09
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +5.0% over 20 sessions. Factor regime → 2026-10-12
  • Sector × region Health care in US: +2.8% week · +3.5% month · +6.2% quarter · +17.8% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-10-11
  • Sovereign pressure Index 0.04 · down 0.71 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-09
How it trades on rate days beta 1.18 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How HIMS has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 1.18 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Hims Hers Health Inc moved 1.18% on average · correlation 0.12 · higher than 92% of US names
  • Beta, last 3 months 2.66 more rate-sensitive lately than over the year
  • On the 10 worst bond days −1.99% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +3.13% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Drug Manufacturers - Specialty & Generic · US · 6 names with week and year-to-date

Peer group

Drug Manufacturers - Specialty & Generic · US

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against HIMS on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Hims Hers Health Inc

HIMS in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Hims & Hers Health runs a direct-to-consumer platform that links patients online with licensed clinicians for prescription and over-the-counter care. It sells personalised treatments and products across skincare, hair care, sexual health, weight loss, hormone health and mental health, alongside lab testing that checks a range of body markers. Consultations, follow-up support and test results are delivered through its website and app, with some products also reaching customers through retail partners and physical stores. The company operates across the United States and several other countries, including the United Kingdom, Canada, Germany, Ireland, France, Spain and Australia, and is based in San Francisco.
Where it sits in the stack
Hims & Hers does not carry a Closelooknet index seat and sits outside the AI build-out stack that our indices track. It belongs instead to the broader healthcare and consumer-health corner of our coverage universe, working as a direct-to-consumer telehealth and specialty drug distributor rather than a supplier to any compute, chip or data-centre layer.
Who it is priced against
The diary has no Closelooknet peer group recorded for Hims & Hers. The comparison the market draws most often is with Teladoc Health, another consumer-facing telehealth business built around remote clinician access.
Why Closelooknet tracks it
Hims & Hers holds no seat in our indices and carries no Closelooknet score across any module. It has not appeared in an edition or a quote so far, so its house-level coverage has not yet begun.
What the diary watches
The diary watches whether direct-to-consumer prescribing keeps expanding into new chronic-condition categories and further countries, which would widen the base for its subscription model.

Hims Hers Health Inc (HIMS) trades on US exchanges, classified under Healthcare.

The Closelooknet company score reads 38/100 composite (momentum 45, quality 31, valuation 20) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 2 analyst actions on the wire · latest: price target by Truist, 2026-08-24

The Street on this name

Analyst actions and the latest print for HIMS from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target Truist — target 32 from 27 Target raised to $32 from $27 (+2.4% to spot) 2026-08-24
  • Price target Barclays — target 35 Target set to $35 (+6.6% to spot) 2026-08-20

2 actions on the analyst wire since 2026-08-13: 2 target changes. Analyst wire → · Earnings wire →

Dividends and capital return no distribution in twelve months · buybacks 90 m USD in FY2025

Dividends and capital return

What HIMS pays out and buys back — distributions read from the price series, money terms from the filings.

  • Distributions No cash distribution recorded in the price series over the last three years
  • Buybacks, FY2025 90 m USD 1.3% of today's market value
  • Share count +9.0% in FY2025 135 m USD of stock-based compensation in the year
  • Capital returned 90 m USD · 122% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-13

Quick answers

What is Hims Hers Health Inc (HIMS)?

Hims Hers Health Inc trades as HIMS on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-10-13.

Is HIMS in a Closelooknet index?

Not currently — Hims Hers Health Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-13.

What is Hims Hers Health Inc's Closelooknet composite score?

38 out of 100, with momentum 45, quality 31 and valuation 20 sub-scores, as of 2026-10-13. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does HIMS trade against its moving averages?

Bullish stack, 200-day still turning: Trades +3.8% vs the 50-day and +11.9% vs the 200-day average, 53.1% below the 52-week high and +123% off the 52-week low; a golden cross printed 52 sessions ago. Computed from daily closes. As of 2026-10-12 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Hims Hers Health Inc compare with its peers?

Against its peer group (Drug Manufacturers - Specialty & Generic · US), Hims Hers Health Inc (HIMS) sits 53.1% below its 52-week high, 3.8% above its 50-day average; Lantheus Holdings Inc (LNTH) is 10.5% below, Kiniksa Pharmaceuticals Ltd (KNSA) is 4.5% below, GALDERMA GROUP AG (GALDY) is 13.2% below. Put any of them next to HIMS in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Hims Hers Health Inc trade when bond yields rise?

Over the past year Hims Hers Health Inc had a beta of 1.18 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 92% of US names. On the 10 sessions in which long bonds fell most it moved −1.99% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Hims Hers Health Inc do?

Hims & Hers Health runs a direct-to-consumer platform that links patients online with licensed clinicians for prescription and over-the-counter care. It sells personalised treatments and products across skincare, hair care, sexual health, weight loss, hormone health and mental health, alongside lab testing that checks a range of body markers. Consultations, follow-up support and test results are delivered through its website and app, with some products also reaching customers through retail partners and physical stores. The diary has no Closelooknet peer group recorded for Hims & Hers. The comparison the market draws most often is with Teladoc Health, another consumer-facing telehealth business built around remote clinician access.

Where does Hims Hers Health Inc sit in the AI build-out?

Hims & Hers does not carry a Closelooknet index seat and sits outside the AI build-out stack that our indices track. It belongs instead to the broader healthcare and consumer-health corner of our coverage universe, working as a direct-to-consumer telehealth and specialty drug distributor rather than a supplier to any compute, chip or data-centre layer. Hims & Hers holds no seat in our indices and carries no Closelooknet score across any module. It has not appeared in an edition or a quote so far, so its house-level coverage has not yet begun.

Does Hims Hers Health Inc pay a dividend?

No cash distribution shows in Hims Hers Health Inc’s price series over the last three years. In fiscal 2025 the company bought back 90 m USD of its own shares, 122% of that year’s free cash flow. The share count rose 9.0% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Hims Hers Health Inc recently?

The most recent analyst action on Hims Hers Health Inc on the Closelooknet wire is a price target by Truist on 2026-08-24 (target 32 from 27). 2 actions on the analyst wire since 2026-08-13: 2 target changes. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for HIMS, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.